PART I ITEM 1 - BUSINESS Overview Impact Biomedical Inc. (IBO. Impact, Impact BioMedical, we, us, our or the Company) discovers, confirms, and patents unique science and technologies which can be developed into new offerings in human healthcare and wellness in collaboration with external partners through licensing, co-development, joint ventures, and other relationships, and currently trades on the NYSE American under ticker symbol IBO. By leveraging technology and new science with strategic par...
Q2 FY2026 — expected 2026-07-22
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-11 | 2025-12-31 | 0001493152-26-009711 | EDGAR | 42K words |
| 2025-03-28 | 2024-12-31 | 0001641172-25-001199 | EDGAR | — |
| 2024-02-20 | 2023-12-31 | 0001493152-24-007229 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-07 | 2025-09-30 | 0001493152-25-021286 | EDGAR | 19K words |
| 2025-08-14 | 2025-06-30 | 0001641172-25-023809 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001641172-25-010276 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001493152-24-044792 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001493152-24-031635 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001493152-24-018663 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001493152-23-040547 | EDGAR | — |
| 2023-10-05 | 2023-06-30 | 0001493152-23-036365 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-04 | 0001493152-26-008879 | EDGAR | 1K words |
| 2025-11-06 | 0001493152-25-021066 | EDGAR | — |
| 2025-10-27 | 0001493152-25-019734 | EDGAR | — |
| 2025-07-28 | 0001641172-25-021085 | EDGAR | — |
| 2025-06-23 | 0001641172-25-016002 | EDGAR | — |
| 2025-04-03 | 0001641172-25-002577 | EDGAR | — |
| 2025-03-28 | 0001641172-25-001060 | EDGAR | — |
| 2025-03-13 | 0001493152-25-010190 | EDGAR | — |
| 2025-01-29 | 0001493152-25-004161 | EDGAR | — |
| 2024-11-04 | 0001493152-24-043558 | EDGAR | — |
50 total filings indexed. 29 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001834105 |
| Ticker | IBO |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
| Website | https://www.impactbiomedinc.com |
| Listed | 2024-09-16 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report